Heron Therapeutics (HRTX) Gross Profit (2017 - 2026)
Heron Therapeutics (HRTX) recorded Gross Profit of $26.09 million in Q2 2026, down 4.6% from $27.34 million a year earlier but up 8.4% from the prior quarter.
Heron Therapeutics (HRTX) Gross Profit (2017 - 2026) Analysis & Trends
On a TTM basis, Heron Therapeutics' Gross Profit came in at $105.94 million as of Jun 30, 2026, down 5.2% year-over-year; for FY2025, it was $113.56 million, up 7.5% from FY2024.
- Annual Gross Profit has increased for five straight years, with a five-year compound annual growth rate of 58.9% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $105.64 million in FY2024 (+70.6%), $61.94 million in FY2023 (+17.3%), $52.8 million in FY2022 (+30.9%) and $40.33 million in FY2021 (+259.6%).
- Quarterly Gross Profit has ranged from $9.71 million in Q4 2021 to $30.55 million in Q4 2024 over the past five years.
- On a year-over-year basis, Gross Profit has declined for three consecutive quarters, with growth averaging 13.6% over the last eight quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 119.8% in Q2 2024, against a decline of 20.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $24.07 million (Q1 2026), $29.47 million (Q4 2025) and $26.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Heron Therapeutics | 66.45 Mn | -123.12 Mn | 26.09 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.09 Mn |
| Mar 31, 2026 | 24.07 Mn |
| Dec 31, 2025 | 29.47 Mn |
| Sep 30, 2025 | 26.30 Mn |
| Jun 30, 2025 | 27.34 Mn |
| Mar 31, 2025 | 30.45 Mn |
| Dec 31, 2024 | 30.55 Mn |
| Sep 30, 2024 | 23.35 Mn |
| Jun 30, 2024 | 25.51 Mn |
| Mar 31, 2024 | 26.23 Mn |
| Dec 31, 2023 | 24.35 Mn |
| Sep 30, 2023 | 13.23 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 12.76 Mn |
| Dec 31, 2022 | 17.40 Mn |
| Sep 30, 2022 | 11.84 Mn |
| Jun 30, 2022 | 11.46 Mn |
| Mar 31, 2022 | 12.10 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | 11.88 Mn |
Heron Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=HRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();